A new study reveals people with schizophrenia have a disrupted stress response. Researchers report those with schizophrenia have an increase in dopamine release in the striatum, but not in the prefrontal cortex, in response to stress.
Researchers report common symptoms of bipolar depression and schizophrenia, such as depression, psychosis and mania, have shared and distinguished genetic risk factors. The findings could help with the development of more effective therapies for these neuropsychological disorders.
According to researchers, Cannabidiol, an active compound in cannabis plants, could help to alleviate cognitive impairment in people with schizophrenia.
Rare structural genetic variants could play a role in the development of schizophrenia.
A new study reports a strong hand grip is correlated with better visual memory and reaction times in people with psychiatric disorders, such as schizophrenia.
A new study reports that 24 hours of sleep deprivation can lead to symptoms similar to schizophrenia in healthy people.
Nineteen gene sets have been identified that contribute to at least five psychiatric disorders. The gene sets were associated with ADHD, ASD, bipolar disorder, major depressive disorder, and schizophrenia.
The largest delay discounting effects were found to be associated with bipolar disorder, borderline personality disorder, and schizophrenia. The image is in the public domain.
A study in Sleep reports on a link between cognition, sleep and a metabolite called kynurenic acid. The metabolite has previously been linked to schizophrenia.
Researchers were able to reverse the neural and behavioral effects of THC exposure and eliminate schizophrenia like symptoms in rats by using drugs to activate GABA, a new study reports.
According to a new study, lithium appears to be safe and effective in treating bipolar disorder in children, at least in the short term.
Study evaluates the effects of regular cannabis use on cortical dopamine function in youth at high risk of psychosis.
